11/26
11:10 am
prld
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
Medium
Report
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
11/20
10:00 am
prld
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
11/19
10:40 am
prld
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
Low
Report
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
11/12
08:21 am
prld
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/12
07:01 am
prld
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/11
11:24 pm
prld
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation With the Schall Law Firm
High
Report
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation With the Schall Law Firm
11/3
09:01 am
prld
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
High
Report
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
10/18
01:31 am
prld
Prelude Therapeutics (NASDAQ:PRLD) was upgraded by analysts at
Wall Stre
Medium
Report
Prelude Therapeutics (NASDAQ:PRLD) was upgraded by analysts at
Wall Stre
11/12/2025
07:01 am
PRLD
prelude therapeutics incorporated
BEAT
Report
5.8%
prelude therapeutics incorporated
8/14/2025
07:00 am
PRLD
prelude therapeutics incorporated
BEAT
Report
2.7%
prelude therapeutics incorporated
5/6/2025
04:05 pm
PRLD
prelude therapeutics incorporated
BEAT
Report
-4.0%
prelude therapeutics incorporated
11/12
07:16 am
prld
Form 10-Q Prelude Therapeutics For: Sep 30
Medium
Report
Form 10-Q Prelude Therapeutics For: Sep 30
11/12
07:08 am
prld
Form 8-K Prelude Therapeutics For: Nov 12
Medium
Report
Form 8-K Prelude Therapeutics For: Nov 12
11/7
04:28 pm
prld
Form 4 Prelude Therapeutics For: Nov 05 Filed by: Sandor Victor
Low
Report
Form 4 Prelude Therapeutics For: Nov 05 Filed by: Sandor Victor
11/7
04:02 pm
prld
Form SCHEDULE 13G Prelude Therapeutics Filed by: INCYTE CORP
Low
Report
Form SCHEDULE 13G Prelude Therapeutics Filed by: INCYTE CORP
10/20
06:50 pm
prld
Form 4 Prelude Therapeutics For: Oct 17 Filed by: Dorton Katina
High
Report
Form 4 Prelude Therapeutics For: Oct 17 Filed by: Dorton Katina
10/20
05:25 pm
prld
Form 3 Prelude Therapeutics For: Oct 17 Filed by: Dorton Katina
High
Report
Form 3 Prelude Therapeutics For: Oct 17 Filed by: Dorton Katina
10/17
07:40 am
prld
Form 8-K Prelude Therapeutics For: Oct 15
Medium
Report
Form 8-K Prelude Therapeutics For: Oct 15
10/7
07:06 am
prld
Form 4 Prelude Therapeutics For: Oct 04 Filed by: Huang Jane
Low
Report
Form 4 Prelude Therapeutics For: Oct 04 Filed by: Huang Jane
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register